glp-1 with cv benefit medications are known for their weight-loss effects, but fewer people may know that they could the heart too. In fact, Wegovy was approved by the FDA to reduce the risk GLP-1 RAs for Diabetic Kidney

Importantly, this success did not arise from the discovery of new biology, but from the translational maturation of a peptide system that had been characterized for decades

Dozens of state AGs asked Meta to enforce policies against misleading weight loss products

In vitro, GLP-1(936) (30 pmol/l) alone did not increase insulin secretion when tested at either glucose concentration

GLP-1 Annals of Internal Medicine GLP-1 26 15,491 34 57 BMI 3041 kg/m liraglutidesemaglutidetirzepatide 9 GLP-1 GLP-1 16 104 43 Tirzepatide15 mg 72 17.8% Semaglutide2.4 mg 68 13.9% Liraglutide3.0 mg 26 5.8% Retatrutide12 mg 48 22.1% GLP-1 47%84% 13%63% 0%26% 0%10% GLP-1 Retatrutide Moiz A, Filion KB, Toutounchi H, et al